These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
197 related items for PubMed ID: 1654449
21. Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat. Tong-Starkesen SE, Luciw PA, Peterlin BM. J Immunol; 1989 Jan 15; 142(2):702-7. PubMed ID: 2536062 [Abstract] [Full Text] [Related]
22. Mycobacterium tuberculosis mannose-capped lipoarabinomannan can induce NF-kappaB-dependent activation of human immunodeficiency virus type 1 long terminal repeat in T cells. Bernier R, Barbeau B, Olivier M, Tremblay MJ. J Gen Virol; 1998 Jun 15; 79 ( Pt 6)():1353-61. PubMed ID: 9634075 [Abstract] [Full Text] [Related]
23. The long terminal repeats of human immunodeficiency virus type-1 and human T-cell leukemia virus type-I are activated by 12-O-tetradecanoylphorbol-13-acetate through different pathways. Mor-Vaknin N, Torgeman A, Galron D, Löchelt M, Flügel RM, Aboud M. Virology; 1997 Jun 09; 232(2):337-44. PubMed ID: 9191847 [Abstract] [Full Text] [Related]
24. Cytomegalovirus activates transcription directed by the long terminal repeat of human immunodeficiency virus type 1. Barry PA, Pratt-Lowe E, Peterlin BM, Luciw PA. J Virol; 1990 Jun 09; 64(6):2932-40. PubMed ID: 2159554 [Abstract] [Full Text] [Related]
25. Transcriptional antagonism of phorbol ester-mediated induction of plasminogen activator inhibitor types 1 and 2 by cyclic adenosine 3',5'-monophosphate. Bergonzelli GE, Kruithof EK, Medcalf RL. Endocrinology; 1992 Sep 09; 131(3):1467-72. PubMed ID: 1354603 [Abstract] [Full Text] [Related]
26. Comparison of the response to T-cell activation by integrated HIV-1 and HTLV-1 LTR-lacZ vectors. Copeland KF, Hendrikx PJ, Haaksma AG, Fiering S, Van Lier R, Goudsmit J, Heeney JL. Virology; 1995 Jun 01; 209(2):633-6. PubMed ID: 7778294 [Abstract] [Full Text] [Related]
27. The cAMP-dependent protein kinase A and protein kinase C-beta pathways synergistically interact to activate HIV-1 transcription in latently infected cells of monocyte/macrophage lineage. Rabbi MF, al-Harthi L, Saifuddin M, Roebuck KA. Virology; 1998 Jun 05; 245(2):257-69. PubMed ID: 9636365 [Abstract] [Full Text] [Related]
28. The NF kappa B independent cis-acting sequences in HIV-1 LTR responsive to T-cell activation. Lu YC, Touzjian N, Stenzel M, Dorfman T, Sodroski JG, Haseltine WA. J Acquir Immune Defic Syndr (1988); 1991 Jun 05; 4(2):173-7. PubMed ID: 1987353 [Abstract] [Full Text] [Related]
29. U5 region of the human immunodeficiency virus type 1 long terminal repeat contains TRE-like cAMP-responsive elements that bind both AP-1 and CREB/ATF proteins. Rabbi MF, Saifuddin M, Gu DS, Kagnoff MF, Roebuck KA. Virology; 1997 Jun 23; 233(1):235-45. PubMed ID: 9201233 [Abstract] [Full Text] [Related]
30. Induction of Sp1 phosphorylation and NF-kappa B-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid. Vlach J, Garcia A, Jacqué JM, Rodriguez MS, Michelson S, Virelizier JL. Virology; 1995 Apr 20; 208(2):753-61. PubMed ID: 7747447 [Abstract] [Full Text] [Related]
31. HIV-1 Nef alters the expression of betaII and epsilon isoforms of protein kinase C and the activation of the long terminal repeat promoter in human astrocytoma cells. Ambrosini E, Slepko N, Kohleisen B, Shumay E, Erfle V, Aloisi F, Levi G. Glia; 1999 Aug 20; 27(2):143-51. PubMed ID: 10417813 [Abstract] [Full Text] [Related]
32. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat. Robinson D, Elliott JF, Chang LJ. Gene Ther; 1995 Jun 20; 2(4):269-78. PubMed ID: 7552987 [Abstract] [Full Text] [Related]
33. ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha. Daniel LW, Civoli F, Rogers MA, Smitherman PK, Raju PA, Roederer M. Cancer Res; 1995 Nov 01; 55(21):4844-9. PubMed ID: 7585518 [Abstract] [Full Text] [Related]
34. Protein kinase A and protein kinase C signaling pathway interaction in phenylethanolamine N-methyltransferase gene regulation. Tai TC, Wong DL. J Neurochem; 2003 May 01; 85(3):816-29. PubMed ID: 12694408 [Abstract] [Full Text] [Related]
35. Mutations of the human cytomegalovirus immediate-early 2 protein defines regions and amino acid motifs important in transactivation of transcription from the HIV-1 LTR promoter. Yeung KC, Stoltzfus CM, Stinski MF. Virology; 1993 Aug 01; 195(2):786-92. PubMed ID: 8337845 [Abstract] [Full Text] [Related]
36. Essential role of NF-kappa B in transactivation of the human immunodeficiency virus long terminal repeat by the human cytomegalovirus 1E1 protein. Kim S, Yu SS, Kim VN. J Gen Virol; 1996 Jan 01; 77 ( Pt 1)():83-91. PubMed ID: 8558131 [Abstract] [Full Text] [Related]
37. Phosphatidylcholine hydrolysis activates NF-kappa B and increases human immunodeficiency virus replication in human monocytes and T lymphocytes. Arenzana-Seisdedos F, Fernandez B, Dominguez I, Jacqué JM, Thomas D, Diaz-Meco MT, Moscat J, Virelizier JL. J Virol; 1993 Nov 01; 67(11):6596-604. PubMed ID: 8411362 [Abstract] [Full Text] [Related]
38. Cytomegalovirus and human herpesvirus-6 trans-activate the HIV-1 long terminal repeat via multiple response regions in human fetal astrocytes. McCarthy M, Auger D, He J, Wood C. J Neurovirol; 1998 Oct 01; 4(5):495-511. PubMed ID: 9839647 [Abstract] [Full Text] [Related]
39. Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists. Mhashilkar AM, Biswas DK, LaVecchio J, Pardee AB, Marasco WA. J Virol; 1997 Sep 01; 71(9):6486-94. PubMed ID: 9261367 [Abstract] [Full Text] [Related]
40. Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells. Kinter AL, Poli G, Maury W, Folks TM, Fauci AS. J Virol; 1990 Sep 01; 64(9):4306-12. PubMed ID: 2200885 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]